169 related articles for article (PubMed ID: 21539305)
41. Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20.
Zhou X; Zhu GD; Van Haver D; Vandewalle M; De Clercq PJ; Verstuyf A; Bouillon R
J Med Chem; 1999 Sep; 42(18):3539-56. PubMed ID: 10479287
[TBL] [Abstract][Full Text] [Related]
42. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
43. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
[TBL] [Abstract][Full Text] [Related]
44. Highly potent cell differentiation-inducing analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modifications.
Fujishima T; Zhaopeng L; Konno K; Nakagawa K; Okano T; Yamaguchi K; Takayama H
Bioorg Med Chem; 2001 Feb; 9(2):525-35. PubMed ID: 11249144
[TBL] [Abstract][Full Text] [Related]
45. Assessment of the free binding energy of 1,25-dihydroxyvitamin D3 and its analogs with the human VDR receptor model.
Kamel K; Kolinski A
Acta Biochim Pol; 2012; 59(4):653-60. PubMed ID: 23074704
[TBL] [Abstract][Full Text] [Related]
46. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
[TBL] [Abstract][Full Text] [Related]
47. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs.
Takayama H; Kittaka A; Fujishima T; Suhara Y
Recent Results Cancer Res; 2003; 164():289-317. PubMed ID: 12899530
[TBL] [Abstract][Full Text] [Related]
49. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
Peräkylä M; Molnár F; Carlberg C
Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
[TBL] [Abstract][Full Text] [Related]
50. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and conformational analysis of 17alpha,21-cyclo-22-unsaturated analogues of calcitriol.
Riveiros R; Rumbo A; Sarandeses LA; Mouriño A
J Org Chem; 2007 Jul; 72(15):5477-85. PubMed ID: 17335235
[TBL] [Abstract][Full Text] [Related]
52. Differential use of transcription activation function 2 domain of the vitamin D receptor by 1,25-dihydroxyvitamin D3 and its A ring-modified analogs.
Peleg S; Nguyen C; Woodard BT; Lee JK; Posner GH
Mol Endocrinol; 1998 Apr; 12(4):525-35. PubMed ID: 9544988
[TBL] [Abstract][Full Text] [Related]
53. Convergent synthesis, chiral HPLC, and vitamin D receptor affinity of analogs of 1,25-dihydroxycholecalciferol.
Odrzywolska M; Chodyński M; Halkes SJ; van de Velde JP; Fitak H; Kutner A
Chirality; 1999; 11(3):249-55. PubMed ID: 10079503
[TBL] [Abstract][Full Text] [Related]
54. 2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation.
Fujishima T; Kittaka A; Kurihara M; Saito N; Honzawa S; Kishimoto S; Sugiura T; Waku K; Takayama H
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):89-92. PubMed ID: 15225752
[TBL] [Abstract][Full Text] [Related]
55. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological activity of 2-(3'-hydroxypropylidene)-1α-hydroxy-19-norvitamin D analogues with shortened alkyl side chains.
Glebocka A; Sicinski RR; Plum LA; Deluca HF
J Med Chem; 2011 Oct; 54(19):6832-42. PubMed ID: 21902235
[TBL] [Abstract][Full Text] [Related]
57. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
González-Avión XC; Mouriño A; Rochel N; Moras D
J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
[TBL] [Abstract][Full Text] [Related]
58. 22S-butyl-1alpha,24R-dihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity.
Inaba Y; Nakabayashi M; Itoh T; Yoshimoto N; Ikura T; Ito N; Shimizu M; Yamamoto K
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):146-50. PubMed ID: 20211257
[TBL] [Abstract][Full Text] [Related]
59. Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry.
Posner GH; Jeon HB; Sarjeant A; Riccio ES; Doppalapudi RS; Kapetanovic IM; Saha U; Dolan P; Kensler TW
Steroids; 2004; 69(11-12):757-62. PubMed ID: 15579327
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluations of A-ring isomers of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
Ikeda M; Takahashi K; Dan A; Koyama K; Kubota K; Tanaka T; Hayashi M
Bioorg Med Chem; 2000 Aug; 8(8):2157-66. PubMed ID: 11003160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
